Compare Deckers Outdoor Corp (DECK) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deckers Outdoor Corp vs Enveric Biosciences Inc — how do they compare? Deckers Outdoor Corp trades at $82.89 (market cap $11.24B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.80M). The key difference: Deckers Outdoor Corp is far larger — about 1652.9× Enveric Biosciences Inc's market cap, and Deckers Outdoor Corp is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Deckers Outdoor Corp for 71 Days and Enveric Biosciences Inc for 14 Days on average.
| DECK | ENVB | |
|---|---|---|
Market Cap | $11.24B | $6.80M |
Volume | 3,010,945 | 64,867 |
Sector | Consumer Cyclical | Health |
52-Week High | $120.94 | $10.80 |
52-Week Low | $77.51 | $1.27 |
Typical Hold Time | 71 Days | 14 Days |
Enterprise Value | $10.11B | -$1.49M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DECK trades at $82.56, up 2.71% today, with a bullish technical signal and strong fundamentals. Recent earnings beats and robust brand momentum from HOKA and UGG support growth. The stock shows high profitability with a net margin of 18.36% and ROE of 42.56%. Valuation ratios like P/E of 11.74 appear attractive relative to earnings power. Support is firm near $81, with resistance at $83.
Outlook remains positive given consistent earnings outperformance and analyst consensus price target of $117.13, implying significant upside. Risks include reliance on key brands and competitive pressures. Institutional interest is strong, but investors should monitor execution on fiscal 2027 growth targets amid economic uncertainties.
ENVB trades at $1.45, down 3.01% today, with a bearish technical signal from moving averages. The company shows negative profitability metrics with ROE at -235.48% and ROA at -193.53%, though it has consistently beaten EPS estimates in recent quarters. Recent positive developments include new patent allowances and preclinical data supporting its non-hallucinogenic drug candidates.
The outlook remains speculative given the lack of revenue and negative cash flow from operations, offset by strong analyst buy ratings (75%). Key risks include clinical trial outcomes and funding needs, while catalysts hinge on regulatory progress and successful drug development in the competitive biotech space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deckers Outdoor Corp
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
